Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Helaina - Nutraceuticals World

What are you searching for?

Sign in

Search by

COMPANY SPOTLIGHT

Helaina

Company Headquarters

345 Park Avenue South, , New York, NY, 10010, US

Driving Directions Phone: View Phone
View website

Request more information from Helaina

Request more information from Helaina

Categories from Helaina

Specialty Ingredients

lactoferrin
effera™ — Unlocking the Benefits of Human Equivalent Lactoferrin — A Market First

Supplier Insights

effera™ — Unlocking the Benefits of Human Equivalent Lactoferrin — A Market First

This versatile ingredient has been clinically studied for safety, quality, and stability, offering manufacturers an efficacious product with reliable supply.

Released By Helaina

Effera™ Human Lactoferrin for Women

Sponsored Content

Effera™ Human Lactoferrin for Women

This novel branded ingredient is the first human equivalent lactoferrin coming to market as a nutrient.

Released By Helaina

Effera™: The First Human Equivalent Lactoferrin on the Market, Backed By Clinical Research

Sponsored Content

Effera™: The First Human Equivalent Lactoferrin on the Market, Backed By Clinical Research

Register for our FREE Webinar

Released By Helaina

Related Content

Market Updates

Nestlé and Helaina to Collaborate on Bioactive Proteins and Early-Life Nutrition

The multi-year partnership brings together Nestlé's expertise in product development with Helaina's biotech capabilities.

By: Sean Moloughney

Effera Lactoferrin

Exclusives

Helaina Scales Manufacturing of effera Lactoferrin to Metric-Tons Level

Producing complex proteins to commercially impactful volumes via precision fermentation has long been a significant hurdle for the industry.

By: Sean Moloughney

Market Updates

Helaina to Showcase World’s First Clinically-Studied Human Lactoferrin Ingredient at Expo West

Effera appeared to offer advantages in inflammatory modulation over bovine lactoferrin.

By: Mike Montemarano

Products & Ingredients

Helaina Raises $45 Million in Series B Funding to Create Human-Equivalent Lactoferrin

The yeast-derived, human-equivalent lactoferrin ingredient is formulated to digest similarly to human lactoferrin, compared to a bovine-sourced counterpart.

By: Mike Montemarano

Research

Effera Lactoferrin Digests Similarly to Human-Sourced Lactoferrin: In Vitro Study

Helaina’s yeast-derived lactoferrin ingredient had similar protein retention and peptide breakdown in a model of digestion than a bovine-sourced counterpart.

By: Mike Montemarano

Market Updates

Biotech Firm Using Precision Fermentation Earns Top Prize at IFT FIRST Competition

Helaina began using precision fermentation to manufacture proteins at scale, starting with lactoferrin.